Abstract: The present invention relates to the use of at least one compound with inhibitory activity on kynurenine 3-hydroxylase for the preparation of a medicament for the prevention and/or treatment of diabetes.
Type:
Grant
Filed:
December 18, 2003
Date of Patent:
June 1, 2010
Assignee:
Merck Patent Gesellschaft mit beschrankter Haftung